Treysta Medical Technologies Inc. — Form D
Treysta Medical Technologies Inc. of GAINESILLE, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-17. The offering totals $300K, of which $90K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-02-17
- Form: D
- Accession: 0002057780-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $90K
- Remaining: $210K
- Investors: 5
- Date of first sale: 2026-01-19
- Revenue range: Decline to Disclose
- SEC file number: 021-573652
Issuer
- Name: Treysta Medical Technologies Inc.
- CIK: 0002057780
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 3733 NORTHWEST 53RD LANE, GAINESILLE, FL, 32653
- Phone: 608-770-0658
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Marcelo Buzzi | Director | Gainesville, FL |
| Nathan Zarnstorff | Director | Gainesville, FL |
| Marcelo Buzzi | Executive Officer | Gainesville, FL |
| Nathan Zarnstorff | Executive Officer | Gainesville, FL |
| Nathan Wolf Zarnstorff | Director | Gainesville, FL |
| Nathan Wolf Zarnstorff | Executive Officer | Gainesville, FL |
| Marcelo Wolf Buzzi | Director | Gainesville, FL |
| Marcelo Wolf Buzzi | Executive Officer | Gainesville, FL |
Other filings by this issuer (1)
More